Literature DB >> 17336031

[Cholera].

Jean-Michel Fournier1, Marie-Laure Quilici.   

Abstract

Cholera is an acute intestinal infection that has reached pandemic proportions and presents a major international health concern. Every year, more than 100000 cholera cases and 2000-3000 deaths are officially reported to WHO. The real figures for cholera are thought to be much higher, however, due to underreporting and other limitations of surveillance systems. Cholera is caused by two serogroups (O1 and O139) of a gram-negative bacterium, Vibrio cholerae. Cholera toxins cause a massive outpouring of electrolyte-rich isotonic fluid into the bowel and can lead to volume depletion and shock. In poor sanitary and individual hygiene conditions, the massive release of cholera vibrios into the environment intensifies and exacerbates cholera epidemics, which thus serve as clear markers of poverty and lack of basic sanitation. Rehydration therapy, either intravenous or oral, considerably decreases the number of deaths. The WHO recommends antibiotics for cholera cases with severe dehydration. If left untreated, cholera has a 25-50% mortality rate. Treatment reduces this to less than 1%. Bacteriological diagnosis of cholera is reasonably easy because cholera bacteria are abundant in stool. Epidemics, however, often occur in areas with either limited or no laboratory facilities. A rapid and accurate diagnosis of cholera is essential to mobilize resources for treatment and containment of the epidemic. Therefore, the Pasteur Institute has developed a rapid diagnostic test based on a one-step immunochromatographic technique, which should be commercially available soon. To date, two oral cholera vaccines have been shown to offer good (more than 70%) short-term (one year) protection. WHO recommends these vaccines as an additional public health tool to be implemented with the standard cholera control measures, including provision of safe drinking water and adequate sanitation. Nonetheless, a cholera vaccine that can offer a long-term protection for all age groups, including children younger than five years, is still needed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17336031     DOI: 10.1016/j.lpm.2006.11.029

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0755-4982            Impact factor:   1.228


  3 in total

1.  Use of filter paper as a transport medium for laboratory diagnosis of cholera under field conditions.

Authors:  Anne-Laure Page; Kathryn P Alberti; Alain Guénolé; Vital Mondongue; Sylvaine Lonlas Mayele; Philippe J Guerin; Marie-Laure Quilici
Journal:  J Clin Microbiol       Date:  2011-06-22       Impact factor: 5.948

2.  The Vibrio cholerae colonization factor GbpA possesses a modular structure that governs binding to different host surfaces.

Authors:  Edmond Wong; Gustav Vaaje-Kolstad; Avishek Ghosh; Ramon Hurtado-Guerrero; Peter V Konarev; Adel F M Ibrahim; Dmitri I Svergun; Vincent G H Eijsink; Nabendu S Chatterjee; Daan M F van Aalten
Journal:  PLoS Pathog       Date:  2012-01-12       Impact factor: 6.823

Review 3.  Cholera in Pregnancy: A Systematic Review and Meta-Analysis of Fetal, Neonatal, and Maternal Mortality.

Authors:  Nguyen-Toan Tran; Richard Taylor; Annick Antierens; Nelly Staderini
Journal:  PLoS One       Date:  2015-07-15       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.